Is COVID Vaccine Maker Moderna Poised To Pop Or Drop?

| Getty Images Key Takeaways Moderna’s stock dropped slightly in early November when it released disappointing financial results for the third quarter of 2022. The company had to slash its original fu...

Moderna Stock Falls Despite Vaccine Sales More Than Tripling From Last Year

Topline Shares of Moderna dropped on Wednesday even after the biotech company reported higher-than-expected revenue and profits in the first quarter, with results boosted by soaring coronavirus vaccin...

Moderna Stock Plunges Despite ‘Vaccine Day’ Touting 31 New Shots And $21 Billion In Sales—Here’s Why

Topline Though Moderna hosted an investor seminar Thursday touting the firm’s growing vaccine pipeline and climbing sales, shares of the Cambridge, Mass.-based biotech firm plunged on Friday as ...

Losses Top $130 Billion After Scientists Find Covid Boosters Aren’t Halting Omicron Infections

Topline Battered by a steep broad-market selloff this week, Moderna shares fell for a sixth-straight day Friday as experts questioned whether Covid-19 vaccine sales alone will help justify the firm...